James E Flynn Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James E Flynn.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

Latest Insider Trading Transactions of James E Flynn

Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS

Page: < prev 1 ... 4 5 6 7 8 9 10 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 28 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.58	7,158	4,152	913,297	920.5 K to 913.3 K (-0.78 %)
Sep 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.59	1,443	851	1,651,012	1.7 M to 1.7 M (-0.09 %)
Sep 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.59	804	474	920,455	921.3 K to 920.5 K (-0.09 %)
Sep 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.58	2	1	1,652,455	1.7 M to 1.7 M (0.00 %)
Sep 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.59	28,553	16,846	1,652,457	1.7 M to 1.7 M (-1.70 %)
Sep 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.59	15,917	9,391	921,259	937.2 K to 921.3 K (-1.70 %)
Sep 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.58	4,559	2,644	1,681,010	1.7 M to 1.7 M (-0.27 %)
Sep 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.58	2,541	1,474	937,176	939.7 K to 937.2 K (-0.27 %)
Sep 17 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.58	192,616	111,717	1,685,569	1.9 M to 1.7 M (-10.26 %)
Sep 17 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.58	107,384	62,283	939,717	1 M to 939.7 K (-10.26 %)
Sep 17 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.59	256,821	151,524	1,878,185	2.1 M to 1.9 M (-12.03 %)
Sep 17 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.59	143,179	84,476	1,047,101	1.2 M to 1 M (-12.03 %)
Sep 17 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.60	40,129	24,077	2,135,006	2.2 M to 2.1 M (-1.84 %)
Sep 17 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.60	22,371	13,423	1,190,280	1.2 M to 1.2 M (-1.84 %)
Aug 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.89	3,780	3,364	2,175,135	2.2 M to 2.2 M (-0.17 %)
Aug 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.89	2,107	1,875	1,212,651	1.2 M to 1.2 M (-0.17 %)
Aug 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.78	642,053	500,801	2,178,915	2.8 M to 2.2 M (-22.76 %)
Aug 23 2010	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Sell	S	0.78	357,947	279,199	1,214,758	1.6 M to 1.2 M (-22.76 %)
Sep 13 2010	MDCO	MEDICINES CO /DE	Flynn James E	10% Owner	Buy	P	13.09	50,188	656,961	3,137,538	3.1 M to 3.1 M (+1.63 %)
Sep 13 2010	MDCO	MEDICINES CO /DE	Flynn James E	10% Owner	Buy	P	13.09	37,861	495,600	2,376,432	2.3 M to 2.4 M (+1.62 %)
Aug 09 2010	MDCO	MEDICINES CO /DE	Flynn James E	10% Owner	Sell	S	11.97	5,762	68,971	3,087,350	3.1 M to 3.1 M (-0.19 %)
Aug 09 2010	MDCO	MEDICINES CO /DE	Flynn James E	10% Owner	Sell	S	11.97	4,365	52,249	2,338,571	2.3 M to 2.3 M (-0.19 %)
Aug 09 2010	MDCO	MEDICINES CO /DE	Flynn James E	10% Owner	Buy	P	12.05	379,546	4,573,529	3,093,112	2.7 M to 3.1 M (+13.99 %)
Aug 09 2010	MDCO	MEDICINES CO /DE	Flynn James E	10% Owner	Buy	P	12.05	287,494	3,464,303	2,342,936	2.1 M to 2.3 M (+13.99 %)
Sep 14 2010	EMLR	Talon Therapeutics ...	Flynn James E	Director	Option Exercise	A	0.74	135	99	4,448
Sep 14 2010	EMLR	Talon Therapeutics ...	Flynn James E	Director	Option Exercise	A	0.74	73	54	2,426
Sep 14 2010	EMLR	Talon Therapeutics ...	Flynn James E	Director	Option Exercise	A	0.74	646	475	21,213
Sep 14 2010	EMLR	Talon Therapeutics ...	Flynn James E	Director	Option Exercise	A	0.74	401	295	13,168
Aug 18 2010	FCSC	Fibrocell Science, ...	Flynn James E	10% Owner	Sell	S	0.69	129,200	89,148	1,162,800	1.3 M to 1.2 M (-10.00 %)
Aug 18 2010	FCSC	Fibrocell Science, ...	Flynn James E	10% Owner	Sell	S	0.69	70,800	48,852	637,200	708 K to 637.2 K (-10.00 %)
Jun 09 2010	EMLR	Talon Therapeutics ...	Flynn James E	Director	Option Exercise	P	0.13	4,313	556	4,313
Jun 09 2010	EMLR	Talon Therapeutics ...	Flynn James E	Director	Option Exercise	P	0.13	2,353	303	2,353
Jun 09 2010	EMLR	Talon Therapeutics ...	Flynn James E	Director	Option Exercise	P	0.13	20,567	2,649	20,567
Jun 09 2010	EMLR	Talon Therapeutics ...	Flynn James E	Director	Option Exercise	P	0.13	12,767	1,644	12,767
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.52	13,598	102,257	1,292,874	1.3 M to 1.3 M (-1.04 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.52	7,702	57,919	733,647	741.3 K to 733.6 K (-1.04 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.86	18,898	148,538	1,306,472	1.3 M to 1.3 M (-1.43 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.86	10,702	84,118	741,349	752.1 K to 741.3 K (-1.42 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.80	20,033	156,257	1,325,370	1.3 M to 1.3 M (-1.49 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.80	11,344	88,483	752,051	763.4 K to 752.1 K (-1.49 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.51	6,271	47,095	1,345,403	1.4 M to 1.3 M (-0.46 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.51	3,552	26,676	763,395	766.9 K to 763.4 K (-0.46 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	12.74	6,565	83,638	1,351,674	1.4 M to 1.4 M (-0.48 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	12.73	3,723	47,394	766,947	770.7 K to 766.9 K (-0.48 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	11,354	83,679	1,358,239	1.4 M to 1.4 M (-0.83 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	6,432	47,404	770,670	777.1 K to 770.7 K (-0.83 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.36	2,750	20,240	1,369,593	1.4 M to 1.4 M (-0.20 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.36	1,561	11,489	777,102	778.7 K to 777.1 K (-0.20 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	20,693	152,507	1,372,343	1.4 M to 1.4 M (-1.49 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	11,756	86,642	778,663	790.4 K to 778.7 K (-1.49 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	18,603	137,104	1,393,036	1.4 M to 1.4 M (-1.32 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	10,560	77,827	790,419	801 K to 790.4 K (-1.32 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	13,184	97,166	1,411,639	1.4 M to 1.4 M (-0.93 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	7,481	55,135	800,979	808.5 K to 801 K (-0.93 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.44	99,788	742,423	1,424,823	1.5 M to 1.4 M (-6.55 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.44	56,612	421,193	808,460	865.1 K to 808.5 K (-6.54 %)
Oct 13 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.75	4,467	30,152	1,524,611	1.5 M to 1.5 M (-0.29 %)
Oct 13 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.75	2,533	17,098	865,072	867.6 K to 865.1 K (-0.29 %)
Oct 13 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	2,937	19,737	1,529,078	1.5 M to 1.5 M (-0.19 %)
Oct 13 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	1,665	11,189	867,605	869.3 K to 867.6 K (-0.19 %)
Oct 01 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.07	2,341	16,551	1,532,015	1.5 M to 1.5 M (-0.15 %)
Oct 01 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.07	1,328	9,389	869,270	870.6 K to 869.3 K (-0.15 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.76	8,932	60,380	1,534,356	1.5 M to 1.5 M (-0.58 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.76	5,068	34,260	870,598	875.7 K to 870.6 K (-0.58 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	12,229	82,179	1,543,288	1.6 M to 1.5 M (-0.79 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	6,939	46,630	875,666	882.6 K to 875.7 K (-0.79 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	634	4,260	1,555,517	1.6 M to 1.6 M (-0.04 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	359	2,412	882,605	883 K to 882.6 K (-0.04 %)
Sep 21 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.73	23,983	161,406	1,556,151	1.6 M to 1.6 M (-1.52 %)
Sep 21 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.73	13,608	91,582	882,964	896.6 K to 883 K (-1.52 %)
Sep 21 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.74	19,695	132,744	1,580,134	1.6 M to 1.6 M (-1.23 %)
Sep 21 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.74	11,174	75,313	896,572	907.7 K to 896.6 K (-1.23 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	18,264	122,696	1,599,829	1.6 M to 1.6 M (-1.13 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	10,361	69,604	907,746	918.1 K to 907.7 K (-1.13 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	19,654	132,075	1,618,093	1.6 M to 1.6 M (-1.20 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	11,151	74,935	918,107	929.3 K to 918.1 K (-1.20 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.71	16,844	113,023	1,637,747	1.7 M to 1.6 M (-1.02 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.71	9,556	64,121	929,258	938.8 K to 929.3 K (-1.02 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.74	14,458	97,447	1,654,591	1.7 M to 1.7 M (-0.87 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.74	8,202	55,281	938,814	947 K to 938.8 K (-0.87 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.77	9,570	64,789	1,669,049	1.7 M to 1.7 M (-0.57 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.77	5,430	36,761	947,016	952.4 K to 947 K (-0.57 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.98	7,048	49,195	952,446	959.5 K to 952.4 K (-0.73 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.97	93,151	649,262	1,678,619	1.8 M to 1.7 M (-5.26 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.97	2,949	20,555	959,494	962.4 K to 959.5 K (-0.31 %)
Jul 15 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.97	162,600	970,722	987,880	1.2 M to 987.9 K (-14.13 %)
Jul 15 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.97	87,552	522,685	537,701	625.3 K to 537.7 K (-14.00 %)
Jul 10 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.97	6,501	38,811	1,150,480	1.2 M to 1.2 M (-0.56 %)
Jul 10 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.97	3,499	20,889	625,253	628.8 K to 625.3 K (-0.56 %)
Jul 10 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.89	8,902	52,433	1,156,981	1.2 M to 1.2 M (-0.76 %)
Jul 10 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.89	4,792	28,225	628,752	633.5 K to 628.8 K (-0.76 %)
Jul 08 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.96	19,404	115,648	1,165,883	1.2 M to 1.2 M (-1.64 %)
Jul 08 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.96	10,447	62,264	633,544	644 K to 633.5 K (-1.62 %)
Jul 08 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.90	15,990	94,341	1,185,287	1.2 M to 1.2 M (-1.33 %)
Jul 08 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.90	8,609	50,793	643,991	652.6 K to 644 K (-1.32 %)
Jul 01 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.99	10,247	61,380	1,201,277	1.2 M to 1.2 M (-0.85 %)
Jul 01 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.99	5,517	33,047	652,600	658.1 K to 652.6 K (-0.84 %)
Jul 01 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.86	164,444	963,642	1,211,524	1.4 M to 1.2 M (-11.95 %)
Jul 01 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.86	3,745	21,946	1,375,968	1.4 M to 1.4 M (-0.27 %)
Jul 01 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.86	89,327	523,456	658,117	747.4 K to 658.1 K (-11.95 %)
Jul 01 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.86	2,033	11,913	747,444	749.5 K to 747.4 K (-0.27 %)
Sep 11 2009	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Option Exercise	P	2.20	1,544,750	3,398,450	1,544,750
Sep 11 2009	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Option Exercise	P	2.20	876,489	1,928,276	876,489
Sep 11 2009	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Buy	P	2.00	1,626,053	3,252,106	2,820,968	1.2 M to 2.8 M (+136.08 %)
Sep 11 2009	NURO	NeuroMetrix, Inc.	Flynn James E	10% Owner	Buy	P	2.00	922,620	1,845,240	1,572,705	650.1 K to 1.6 M (+141.92 %)
Jun 19 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	5.96	17,547	104,580	1,771,770	1.8 M to 1.8 M (-0.98 %)
Jun 19 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	5.96	9,531	56,805	962,443	972 K to 962.4 K (-0.98 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.87	1,519	8,917	1,379,713	1.4 M to 1.4 M (-0.11 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.73	6,035	34,581	1,381,232	1.4 M to 1.4 M (-0.44 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.87	825	4,843	749,477	750.3 K to 749.5 K (-0.11 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.73	3,278	18,783	750,302	753.6 K to 750.3 K (-0.43 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	6.08	3,305	20,094	1,387,267	1.4 M to 1.4 M (-0.24 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	6.10	16,200	98,820	1,390,572	1.4 M to 1.4 M (-1.15 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	6.05	3,750	22,688	1,406,772	1.4 M to 1.4 M (-0.27 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	6.08	1,795	10,914	753,580	755.4 K to 753.6 K (-0.24 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	6.10	8,800	53,680	755,375	764.2 K to 755.4 K (-1.15 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	6.05	2,037	12,324	764,175	766.2 K to 764.2 K (-0.27 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.90	5,744	33,890	1,410,522	1.4 M to 1.4 M (-0.41 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	6.77	17,445	118,103	1,416,266	1.4 M to 1.4 M (-1.22 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	5.90	3,119	18,402	766,212	769.3 K to 766.2 K (-0.41 %)
Jun 25 2009	NGSX	NeurogesX Inc	Flynn James E	10% Owner	Sell	S	6.77	9,475	64,146	769,331	778.8 K to 769.3 K (-1.22 %)
Apr 27 2009	NTMD	NITROMED INC	Flynn James E	10% Owner	Buy	P	0.86	46,085,133	39,564,087	46,085,133	0 to 46.1 M
Apr 27 2009	NTMD	NITROMED INC	Flynn James E	10% Owner	Sell	J	0.86	3,281,497	2,817,165	0	3.3 M to 0 (-100.00 %)
Apr 27 2009	NTMD	NITROMED INC	Flynn James E	10% Owner	Sell	J	0.86	1,783,019	1,530,722	0	1.8 M to 0 (-100.00 %)
Jun 26 2009	DUSA	DUSA PHARMACEUTICA ...	Flynn James E	10% Owner	Buy	P	0.90	274,104	246,694	1,952,648	1.7 M to 2 M (+16.33 %)
Jun 26 2009	DUSA	DUSA PHARMACEUTICA ...	Flynn James E	10% Owner	Buy	P	0.90	148,896	134,006	1,064,317	915.4 K to 1.1 M (+16.27 %)
Mar 02 2009	EMAG	EMAGEON INC	Flynn James E	10% Owner	Sell	S	1.75	397,258	695,202	1,173,658	1.6 M to 1.2 M (-25.29 %)
Mar 02 2009	EMAG	EMAGEON INC	Flynn James E	10% Owner	Sell	S	1.75	216,742	379,299	640,342	857.1 K to 640.3 K (-25.29 %)
Mar 13 2009	DUSA	DUSA PHARMACEUTICA ...	Flynn James E	10% Owner	Buy	P	1.21	162,000	196,020	1,678,544	1.5 M to 1.7 M (+10.68 %)
Mar 13 2009	DUSA	DUSA PHARMACEUTICA ...	Flynn James E	10% Owner	Buy	P	1.21	88,000	106,480	915,421	827.4 K to 915.4 K (+10.64 %)
Feb 25 2009	DUSA	DUSA PHARMACEUTICA ...	Flynn James E	10% Owner	Sell	S	1.08	130	140	1,516,544	1.5 M to 1.5 M (-0.01 %)
Feb 25 2009	DUSA	DUSA PHARMACEUTICA ...	Flynn James E	10% Owner	Sell	S	1.07	19,183	20,526	1,516,674	1.5 M to 1.5 M (-1.25 %)
Feb 25 2009	DUSA	DUSA PHARMACEUTICA ...	Flynn James E	10% Owner	Sell	S	1.08	70	76	827,421	827.5 K to 827.4 K (-0.01 %)
Feb 25 2009	DUSA	DUSA PHARMACEUTICA ...	Flynn James E	10% Owner	Sell	S	1.07	10,465	11,198	827,491	838 K to 827.5 K (-1.25 %)
Dec 24 2008	NTMD	NITROMED INC	Flynn James E	10% Owner	Sell	S	0.52	7,081	3,682	3,281,497	3.3 M to 3.3 M (-0.22 %)
Dec 24 2008	NTMD	NITROMED INC	Flynn James E	10% Owner	Sell	S	0.52	3,846	2,000	1,783,017	1.8 M to 1.8 M (-0.22 %)
Dec 24 2008	NTMD	NITROMED INC	Flynn James E	10% Owner	Sell	S	0.56	291,512	163,247	3,288,578	3.6 M to 3.3 M (-8.14 %)
Dec 24 2008	NTMD	NITROMED INC	Flynn James E	10% Owner	Sell	S	0.56	158,392	88,700	1,786,863	1.9 M to 1.8 M (-8.14 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.24	276,493	66,358	0	276.5 K to 0 (-100.00 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.22	56,742	12,636	276,493	333.2 K to 276.5 K (-17.03 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.27	533,176	141,771	333,235	866.4 K to 333.2 K (-61.54 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.24	138,370	33,209	0	138.4 K to 0 (-100.00 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.22	28,395	6,324	138,370	166.8 K to 138.4 K (-17.03 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.27	266,824	70,949	166,765	433.6 K to 166.8 K (-61.54 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.24	195,563	47,228	0	195.6 K to 0 (-100.00 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.23	225,156	50,930	195,563	420.7 K to 195.6 K (-53.52 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.24	317,000	75,858	420,719	737.7 K to 420.7 K (-42.97 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.23	41,123	9,339	737,719	778.8 K to 737.7 K (-5.28 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.28	95,100	26,580	778,842	873.9 K to 778.8 K (-10.88 %)
Oct 24 2008	DVAX	DYNAVAX TECHNOLOGI ...	Flynn James E	10% Owner	Sell	S	0.25	63,400	15,850	873,942	937.3 K to 873.9 K (-6.76 %)

Page: < prev 1 ... 4 5 6 7 8 9 10 next >